Abu Dhabi doctors freeze 5 embryos for 30-year-old ovarian cancer patient

SEHA’s Corniche Fertility Centre in Abu Dhabi froze 5 embryos for a 30-year-old ovarian cancer patient before chemotherapy began, according to a Gulf News report carried in UAE media on 16 September 2026.

The highest-stakes readers are COOs, medical directors and insurers. The case is operationally simple but time-sensitive: oncology teams must identify fertility risk before treatment, fertility centres must move within days, and payers must decide whether fertility preservation is a covered cancer-care adjunct or a self-pay add-on.

What happened in Abu Dhabi

The patient had a recurrent juvenile granulosa cell tumour of the ovary and needed chemotherapy, which can affect fertility. Her oncology team referred her to SEHA’s Corniche Fertility Centre. The first fertility consultation took place within 1 week of referral, ovarian stimulation started the next day, and eggs from her remaining ovary were retrieved, fertilised and frozen as embryos.

“Early referral and close coordination between oncology and reproductive medicine teams allow us to provide effective fertility preservation without compromising cancer care timelines.”
Dr Arianna D’Angelo, Consultant Physician, SEHA’s Corniche Fertility Centre

For UAE providers, the clinical lesson is the deadline. Fertility preservation for cancer patients usually has to be discussed before chemotherapy or pelvic radiotherapy begins. In this case, the fertility work was completed inside the available oncology window, allowing chemotherapy to start as planned.

Why Dubai clinics should care

In Dubai, the relevant regulator is the Dubai Health Authority (DHA). DHA’s Standards for Assisted Reproductive Medicine Centers list federal fertility laws and require consent controls for cryopreservation. The standard was issued on 31 December 2025, became effective on 28 February 2026, and is due for revision on 31 December 2029.

Dubai oncology clinics should treat this as a pathway-design issue. A patient aged 30 with ovarian cancer cannot wait for an informal referral chain. The useful workflow is a written fertility-risk prompt at diagnosis, a same-day referral option to a licensed fertility centre, and a pre-authorisation script for insurers where the patient has maternity or oncology benefits.

• COO: build a referral target of 24 to 48 hours for eligible reproductive-age cancer patients.
• CFO: separate chemotherapy authorisation from fertility-preservation estimates, because delays can create clinical and financial exposure.
• Medical director: document fertility counselling before gonadotoxic treatment where medically appropriate.
• CIO: add a fertility-risk field to oncology intake templates and tumour-board notes.

Costs, cover and patient risk

Self-pay prices vary by clinic, drug dose and storage period. Public price pages from UAE fertility providers show that egg freezing can start around AED 15,500 at ART Fertility Clinics Dubai, while IVF packages can start around AED 39,000. MMC IVF lists IVF-related ranges of AED 12,500 to AED 18,000 for one service category and AED 5,500 to AED 11,000 for frozen embryo transfer. These figures are tariff signals, not a cancer-specific bill.

Insurers should not assume one rule fits all cases. Daman and Thiqa are central to many Abu Dhabi coverage discussions, while Sukoon is a major UAE private insurer, but fertility preservation cover depends on the plan, network, diagnosis code, authorisation rules and whether the fertility procedure is linked to cancer treatment. Patients should request a written estimate with CPT or local billing codes, storage fees, medication costs and renewal terms before stimulation starts.

In Abu Dhabi and Al Ain, the regulator is the Department of Health Abu Dhabi (DOH). In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, the federal reference point is the Ministry of Health and Prevention (MOHAP), alongside local licensing where applicable. Operators with branches across emirates need one clinical protocol but separate licence checks for each site.

The next question is whether UAE oncology networks will make fertility preservation a standard pre-treatment checkpoint for younger patients. Clinics that already run tumour boards can add one line to the agenda: has fertility risk been discussed and documented? Patients and operators looking for licensed oncology services should use the UAE Open Healthcare Directory to identify oncology providers and verify local licensing before booking care.